ABBV vs AMPH · P/E 81, rev $61.16B vs P/E 12, rev $732.0M
AbbVie Inc (ABBV) versus Amphastar P (AMPH) — a side-by-side from cached financials, not a winner call.
AbbVie Inc (ABBV) is a drug manufacturers - general company listed on US. It is led by Rob Michael.
Amphastar P (AMPH) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported ABBV revenue for 2025-12-31 was $61.16B. Net income was $4.23B. Revenue was up 305.0% from 2024-12-31 to 2025-12-31. ABBV currently screens at market cap $334.34B and trailing P/E 80.5.
Latest reported AMPH revenue for 2024-12-31 was $732.0M. Net income was $159.5M. Revenue was up 13.6% from 2023-12-31 to 2024-12-31. AMPH currently screens at market cap $880.1M and trailing P/E 12.0.
ABBV currently screens at market cap $334.34B and trailing P/E 80.5. AMPH currently screens at market cap $880.1M and trailing P/E 12.0.
Not investment advice. Open the ABBV and AMPH stock pages for the full models.
Not investment advice.